Korean J Fertil Steril Search

CLOSE


Clin Exp Reprod Med > Epub ahead of print
Puangsricharoen, Tuntiviriyapun, Ngeamvijavat, and Sukcharoen: Agreement between home sperm testing and computer-assisted and manual semen analysis for motile sperm concentration

Abstract

Objective

To evaluate the agreement of motile sperm concentration (MSC) measurements obtained using the YO Home Sperm Test compared with manual semen analysis and computer-assisted semen analysis (CASA), and to assess its potential utility as a home-based screening tool for male fertility.

Methods

Semen samples from 40 men were analyzed using three methods: the YO Home Sperm Test, manual semen analysis with a Makler counting chamber, and CASA using the Integrated Visual Optical System analyzer. Agreement between methods was assessed using intraclass correlation coefficients (ICCs) with 95% confidence intervals (CIs).

Results

The three testing methods showed significant correlations (p<0.01), with an overall ICC of 0.902. Pairwise ICCs were 0.815 (95% CI, 0.651 to 0.902) between manual semen analysis and the YO Home Sperm Test, 0.793 (95% CI, 0.608 to 0.890) between manual semen analysis and CASA, and 0.944 (95% CI, 0.894 to 0.970) between the YO Home Sperm Test and CASA. Agreement was strongest between the YO Home Sperm Test and CASA, supporting the reliability of the home-based device for measuring MSC.

Conclusion

The YO Home Sperm Test demonstrated good agreement with both manual semen analysis and CASA, particularly with CASA, supporting its potential use as a convenient, accessible, and private screening tool for the initial evaluation of male fertility. However, as a screening device rather than a comprehensive diagnostic test, abnormal findings should be confirmed by standard laboratory semen analysis. Further studies in larger populations and across different smartphone platforms are warranted.

Introduction

Sperm motility is one of the most important parameters for predicting fertility outcomes [1,2]. Motile sperm concentration (MSC), a key measurement derived from semen analysis, integrates sperm concentration and motility into a single clinically relevant parameter. Standard semen analysis, performed according to World Health Organization (WHO) guidance, remains the most widely used approach [3]. However, sperm motility assessment is technically challenging because it requires skilled personnel, specialized equipment, and substantial time. Microscopic examinations based on manual counting are subject to considerable interobserver variability, and result accuracy depends largely on examiner expertise [4]. Conventional semen analysis therefore has important practical limitations, particularly in settings with limited laboratory resources.
To improve accessibility and convenience, several home-based semen testing systems have recently been developed. Smartphone-based platforms are relatively affordable and easy to use because they use the built-in camera of a mobile device, although computer- and laptop-based systems are also available. These tools may help men assess fertility status earlier and with fewer logistical barriers [5-7]. In addition, semen samples collected at home may have higher sperm concentration and motility than samples collected in clinical settings [8].
The YO Home Sperm Test is a smartphone-based semen analysis platform approved by the U.S. Food and Drug Administration (FDA) [5,9]. The system combines optical imaging technology with proprietary image-processing algorithms to evaluate sperm motility. A miniature microscope attachment allows the smartphone camera to capture videos of sperm movement, and the software analyzes changes in pixel intensity generated by moving spermatozoa to estimate MSC. This approach provides a rapid, user-friendly alternative to conventional laboratory-based semen analysis while maintaining analytical performance suitable for fertility screening [5].
This study evaluated the agreement between MSC measurements obtained with the YO Home Sperm Test and those generated by standard laboratory methods, including computer-assisted semen analysis (CASA) and manual semen analysis. Because MSC incorporates both sperm concentration and motility, it may provide clinically useful information about male fertility potential.
In Thailand, both home sperm testing and CASA are currently available. Our results may be particularly useful as these tools become more widely available in developing countries.

Methods

The study protocol was approved by the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University (IRB 0366/2564). Written informed consent was obtained from all participants. Semen samples were obtained from the Reproductive Medicine Unit and included samples from both patients undergoing fertility evaluation and volunteers. The sample size was calculated using the methodology reported by Agarwal et al. [9]. Assuming an expected intraclass correlation coefficient (ICC) of 0.90, a minimally acceptable ICC of 0.80, α=0.05, and β=0.20, the minimum required sample size was 28 participants. To improve precision and account for potential exclusions, 40 participants were enrolled.
A total of 40 semen samples were collected by masturbation into clean, wide-mouthed plastic containers after 2 to 7 days of sexual abstinence. Samples were maintained at 37 °C and allowed to liquefy before analysis. Semen volume and sperm motility were initially assessed using the wet preparation method described in the WHO fifth-edition manual [3]. Each sample was divided equally into three aliquots and analyzed separately by manual semen analysis, CASA, and the YO Home Sperm Test. All assessments were performed immediately after liquefaction to minimize time-dependent changes in sperm motility.
Manual semen analysis was performed using a Makler chamber. A 5-µL aliquot of well-mixed, undiluted semen was placed in the center of the chamber to determine sperm concentration. The chamber contains a 1-mm² grid subdivided into 100 squares, and sperm concentration was calculated from the number of sperm heads counted in 10 designated squares. For motility assessment, 5 µL of a well-mixed specimen was loaded into the Makler chamber, allowing sperm to move freely within the observation field [10]. The slide was examined using phase-contrast optics at 200× magnification. Approximately 200 spermatozoa were immediately counted and classified as progressive, non-progressive, or immotile. Sperm vitality was assessed using eosin-nigrosin staining, which enhances contrast between sperm heads and the background, and slides were examined under bright-field microscopy [3]. Sperm concentration and vitality were independently assessed by two experienced observers (Pimpitcha Puangsricharoen and Jiraporn Ngeamvijavat), and results were compared on a cell-by-cell basis.
CASA was performed using the Hamilton Thorne Integrated Visual Optical System motility analyzer (version 12.0; Hamilton Thorne) (Figure 1). Samples were loaded into a fixed-depth Makler chamber using a 5-µL aliquot. The system recorded images at 60 images/sec. Sperm cells could swim freely along the x- and y-axes but were limited in the z-axis. Total sperm concentration (million/mL), total motility (%), and progressive motility (%) were calculated automatically. Sperm movement was categorized as rapid progressive (≥25 µm/sec), slow progressive (<25 and ≥5 µm/sec), non-progressive motile (<5 µm/sec), or immotile [11].
For the YO Home Sperm Test, manufacturer-provided liquefaction powder was added immediately after sample collection. Liquefied semen was placed on a fixed-coverslip testing slide until the loading area was filled. The slide was then inserted into the smartphone-mounted optical attachment. Results were reported as a YO Score, a proprietary semi-quantitative index representing MSC percentile ranges derived from WHO reference populations (Medical Electronic Systems Ltd., unpublished technical documentation) [9]. MSC values obtained from manual semen analysis, CASA, and the YO Home Sperm Test were compared.

1. Device overview

The principle of home mobile sperm testing is based on video recording of sperm movement, in which alterations in sperm movement are interpreted as pixel-level light-signal changes and converted into MSC by the device algorithm. The YO Home Sperm Test received U.S. FDA approval in 2016. It can be used with iPhone, Galaxy, and macOS devices. The device kit includes a plastic cup for sample collection, liquefaction powder, fixed-volume transfer pipettes, and a plastic test slide with a fixed coverslip (Figure 2).
A clip is attached to the top of a smartphone with a camera resolution of 1,920×1,080 pixels or higher. Backlight from the smartphone illuminates the sample on a fixed-coverslip slide and projects the image through two angled mirrors based on the principle of light reflection. The light is then diverted to a ball lens at 100× magnification and reaches the charge-coupled device of the smartphone. During testing, a 30-second video is recorded, and proprietary image-processing algorithms analyze temporal changes in pixel intensity generated by moving spermatozoa. These optical signals are converted into estimates of MSC (Figure 3). In this study, testing was performed using an iPhone 8 Plus equipped with a 12-megapixel camera and the YO application (version 1.0) downloaded from the App Store.
After approximately 2 minutes of analysis, the result was displayed as moderate/normal MSC (≥6.0 million/mL) or low MSC (<6.0 million/mL). The YO Score reports results in 10–90+ MSC percentile levels based on the WHO fifth edition [9].

2. Statistical analysis

Demographic data are presented as mean±standard deviation for normally distributed variables. Non-normally distributed variables are presented as median (range). The ICC was used to evaluate agreement in MSC between methods. ICC values are reported on a scale from 0 to 1.0. ICC values of <0.5, 0.5–0.75, 0.75–0.90, and >0.90 were interpreted as indicating poor, moderate, good, and excellent reliability, respectively. An exploratory post hoc subgroup analysis was performed using an MSC threshold of 30×10⁶/mL. This threshold was selected based on visual inspection of agreement plots and the categorical reporting structure of the YO Home Sperm Test, which suggested increased variability at higher MSC values. Statistical analyses were performed using SPSS version 22.0 (IBM Co.).

Results

Table 1 summarizes the baseline characteristics of the 40 participants. The mean age was 36±6.1 years, and the mean body mass index was 22.5±2.8 kg/m². On manual semen analysis, mean semen volume was 2.3±0.7 mL, median sperm concentration was 41.8×10⁶/mL (range, 8 to 114), median sperm motility was 44.8% (range, 24% to 71%), and median MSC was 13.9×10⁶/mL (range, 2 to 61). Table 2 summarizes the CASA and YO Home Sperm Test results. With CASA, median sperm concentration was 18.6×10⁶/mL (range, 4 to 75), median sperm motility was 72.6% (range, 23.1% to 91.6%), and median MSC was 13.2×10⁶/mL (range, 0.4 to 63.8). The median YO Home Sperm Test score was 20 (range, 0 to 60).
Comparison of MSC among the three methods demonstrated significant agreement (p<0.01), with an overall ICC of 0.902. Agreement between manual semen analysis and the YO Home Sperm Test yielded an ICC of 0.815 (95% confidence interval [CI], 0.651 to 0.902) (Figure 4). Agreement between manual semen analysis and CASA yielded an ICC of 0.793 (95% CI, 0.608 to 0.890) (Figure 5), whereas agreement between the YO Home Sperm Test and CASA yielded an ICC of 0.944 (95% CI, 0.894 to 0.970) (Figure 6). Agreement between methods was further evaluated using Bland–Altman analysis (Figures 4-6). Visual inspection of the scatter plots and Bland–Altman plots suggested closer agreement at lower MSC values and greater variability at higher concentrations.
In the exploratory subgroup analysis of samples with MSC <30×10⁶/mL by manual semen analysis, agreement between manual semen analysis and the YO Home Sperm Test yielded an ICC of 0.675 (95% CI, 0.317 to 0.845) (Figure 7). For the comparison between the YO Home Sperm Test and CASA, the subgroup with MSC <30×10⁶/mL yielded an ICC of 0.930 (95% CI, 0.854 to 0.967), whereas the subgroup with MSC ≥30×10⁶/mL yielded an ICC of 0.845 (95% CI, 0.378 to 0.962) (Figure 8).

Discussion

Semen analysis is central to the evaluation of male infertility. Laboratory-based methods, including manual semen analysis and CASA, are commonly used. However, these methods require trained personnel and laboratory infrastructure and may be affected by subjectivity and human error [3,12]. CASA and other automated sperm analyzers, such as the Sperm Quality Analyzer (SQA-Vision; Medical Electronic Systems), offer higher specificity but are limited by cost, size, and restricted field of view, which may constrain their use, particularly in field studies [5].
A study of 105 men demonstrated significant correlations in total sperm concentration and motility among SQA-V, manual semen analysis, and CASA. These findings support the comparative reliability of different semen analysis methods [13].
The introduction of home-based sperm testing devices has improved privacy and may reduce stress during fertility evaluation. These devices have become more widely used, although most measure only sperm concentration and do not assess key parameters such as motility [7,14-17]. In the present study, we used the YO device, one of the few U.S. FDA-approved home sperm testing systems that reports MSC.
To our knowledge, limited data are available on the agreement among smartphone-based home sperm testing, manual semen analysis, and CASA. The present study was designed to address this evidence gap. A notable finding was the stronger agreement between home sperm testing and CASA, possibly because both methods use more objective analytic approaches than the manual counts required in standard semen analysis. This finding suggests that home sperm testing may be a viable screening alternative, particularly for men with fertility concerns.
Previous studies have evaluated the accuracy and agreement of home sperm testing with professional analyzers such as SQA-Vision. These studies have consistently reported strong correlations and high precision in MSC measurements, supporting the reliability of home sperm testing [9,18].
In 2018, Agarwal et al. [9] analyzed 144 aliquots from 24 sperm donors to compare MSC values measured by the YO device on Galaxy and iPhone platforms with those measured by the SQA-Vision analyzer. SQA-Vision uses optoelectronics, computer algorithms, and video microscopy. They found that MSC measured by YO correlated strongly with SQA results, with an ICC of 0.9309 [9]. After testing, data were displayed as “normal” or “low” MSC using a cutoff of 6 million. Several studies have supported this parameter. A report of 1,082 fertile men showed an MSC threshold of 4.0×10⁶/mL [19]. Redmon et al. [20] further characterized semen parameters in 763 fertile U.S. men, reporting a mean sperm concentration of 60×10⁶/mL and mean motility of 51%, although MSC was not directly reported.
Honig et al. [18] compared the YO mobile device with SQA in 2019 and reported high precision for MSC calculation. In that study, 316 semen samples were analyzed. SQA was used as the comparator because it had shown a Spearman coefficient of 0.96 with manual analysis. The device demonstrated high positive predictive agreement (97.6%) and negative predictive agreement (97%). Between trained professionals and SQA-V, MSC results showed an accuracy of 97.3% [18].
Compared with laboratory-based CASA systems, which require specialized equipment and trained personnel, smartphone-based home tests are substantially less expensive and more accessible [17,21]. This may be particularly relevant in resource-limited settings where access to fertility laboratories is restricted. Agreement between the YO Home Sperm Test and CASA appeared stronger at lower MSC values than at higher concentrations. Notably, the 30×10⁶/mL threshold was identified through an exploratory post hoc analysis and was not prespecified in the study design. Therefore, this finding should be considered hypothesis-generating and requires validation in larger independent cohorts. This pattern may reflect the semi-quantitative nature of the device, which reports MSC values in discrete categories rather than as continuous measurements. Importantly, the primary clinical role of home sperm testing devices is screening for impaired semen quality. Therefore, reduced precision at higher MSC values may have limited clinical significance, because men with values substantially above clinically relevant thresholds would generally not be reclassified into different clinical management categories.
Male infertility is multifactorial, and semen parameters such as motility contribute to fertility assessment. Evidence suggests that combining motility and concentration data provides a more accurate assessment than morphology alone [15,22,23]. However, most home semen testing devices do not provide a comprehensive semen analysis; many report sperm concentration alone, whereas some newer devices provide additional or composite measures such as motile sperm concentration.
Several limitations should be considered. First, the study population consisted primarily of Asian men with a mean age of 36 years. Although this provides useful information for the target population, it may limit the generalizability of the findings to other ethnic and geographic populations. Second, the testing sequence was not randomized. Although all analyses were performed promptly after liquefaction, sperm motility may decline over time after ejaculation, and minor time-dependent changes may have contributed to differences between methods. Third, only a single smartphone model (iPhone 8 Plus) was evaluated. Differences in camera sensors, image-processing pipelines, and operating systems may influence performance across smartphone models. Although previous validation studies have demonstrated high accuracy across both iPhone and Android platforms, additional studies examining inter-device variability and compatibility across smartphone platforms are warranted [24].
User error and variability in sample handling during home testing may also affect results. Consequently, home sperm testing should currently be considered a screening tool rather than a replacement for comprehensive laboratory semen analysis [6]. Differences in sample handling, device operation, and result interpretation may contribute to variability when the test is used outside controlled laboratory settings. Future studies should investigate strategies to minimize these factors through standardized user instructions and improved device design.
Future home sperm testing platforms may benefit from reporting additional semen parameters, including progressive motility and other detailed kinetic measurements, to enhance clinical utility. Although the present study focused on MSC, other semen parameters, such as sperm morphology and DNA fragmentation, are also important components of fertility assessment and should be considered in future device development and validation studies [6].
Further research is needed to determine how home sperm testing can be integrated into existing fertility assessment protocols. Future studies should compare these devices with standard clinical practice in terms of diagnostic performance, convenience, patient acceptability, and cost-effectiveness. In addition, studies evaluating different MSC concentration ranges, real-world patient self-testing, and long-term reproductive outcomes, including pregnancy rates, would provide valuable insight into the clinical utility and reliability of home sperm testing devices.
In this study, the YO Home Sperm Test showed agreement with standard manual semen analysis and CASA for the assessment of MSC. These findings support its potential role as a convenient, private, and accessible screening tool for the initial evaluation of male fertility. The device may facilitate earlier fertility assessment and improve participation in male infertility evaluation. Further studies are needed to validate these findings in larger and more diverse populations and to assess performance across different smartphone platforms and clinical settings.

Conflict of interest

No potential conflict of interest relevant to this article was reported.

Acknowledgments

The authors thank Assistant Professor Charoen Taweepolcharoen, MD, and Associate Professor Apichai Vasuratna, MD, for their guidance on this project. The authors also thank Michael D. Ulman, PhD, for English-language editing.

Author contributions

Conceptualization: NS. Methodology: PP, PT, NS. Formal analysis: PP. Data curation: PT. Funding acquisition: PT. Project administration: PP. Visualization: JN. Investigation: PP, JN. Supervision: NS. Writing-original draft: PP. Writing-review & editing: PT, NS. Approval of final manuscript: PP, PT, JN, NS.

Figure 1.
Study flowchart. CASA, computer-assisted semen analysis.
cerm-2026-09194f1.jpg
Figure 2.
YO Home Sperm Test device. (A) Components of the testing kit: (a) testing clip, (b) collection cup, (c) liquefaction powder, (d) fixed-volume transfer pipettes, and (e) fixed-coverslip testing slide. (B) Sample loading with a disposable plastic pipette to place the sample onto the slide loading area, highlighted in pink. (C) Assembled testing clip with an inserted slide attached to a smartphone. (D) Example test results displayed according to motile sperm concentration (MSC) percentile categories. Photograph by the authors.
cerm-2026-09194f2.jpg
Figure 3.
Optical principle of the YO Home Sperm Test. (A) Schematic representation of the optical system. A backlight illuminates the specimen within the fixed-coverslip slide. Transmitted light passes through a ball lens, which magnifies the image before projection onto the smartphone camera lens and charge-coupled device (CCD) sensor. (B) Sample loading with a disposable plastic pipette to place the sample onto the slide loading area. (C) Side view of the smartphone, clip, and slide. Image edited by the authors from Medical Electronic Systems Ltd. (2019). LED, light emitting diode.
cerm-2026-09194f3.jpg
Figure 4.
Agreement between manual semen analysis and the YO Home Sperm Test. (A) Scatter plot of motile sperm concentration (MSC, ×10⁶/mL) measured by manual semen analysis (x-axis) and the YO Home Sperm Test (y-axis). (B) Bland–Altman plot showing agreement between the two methods. The solid horizontal line represents the mean difference, and the dashed lines represent the 95% limits of agreement (mean difference ±1.96 standard deviation). ICC, intraclass correlation coefficient; CI, confidence interval.
cerm-2026-09194f4.jpg
Figure 5.
Agreement between manual semen analysis and computer-assisted semen analysis (CASA). (A) Scatter plot of motile sperm concentration measured by manual semen analysis and CASA. (B) Bland–Altman plot showing agreement between methods. The solid horizontal line represents the mean difference, and the dashed lines represent the 95% limits of agreement. ICC, intraclass correlation coefficient; CI, confidence interval; SD, standard deviation.
cerm-2026-09194f5.jpg
Figure 6.
Agreement between the YO Home Sperm Test and computer-assisted semen analysis (CASA). (A) Scatter plot of motile sperm concentration measured by the YO Home Sperm Test and CASA. (B) Bland–Altman plot showing agreement between methods. The solid horizontal line represents the mean difference, and the dashed lines represent the 95% limits of agreement. ICC, intraclass correlation coefficient; CI, confidence interval; SD, standard deviation.
cerm-2026-09194f6.jpg
Figure 7.
Scatter plots comparing motile sperm concentration (MSC) measured by the YO Home Sperm Test and manual semen analysis according to MSC level. (A) MSC <30×10⁶ cells/mL. (B) MSC ≥30×10⁶ cells/mL. ICC, intraclass correlation coefficient; CI, confidence interval.
cerm-2026-09194f7.jpg
Figure 8.
Scatter plots comparing motile sperm concentration (MSC) measured by the YO Home Sperm Test and computer-assisted semen analysis (CASA) according to MSC level. (A) MSC <30×10⁶ cells/mL. (B) MSC ≥30×10⁶ cells/mL. ICC, intraclass correlation coefficient; CI, confidence interval.
cerm-2026-09194f8.jpg
Table 1.
Baseline semen parameters measured by manual semen analysis (WHO 2010 criteria)
Variable Value
Age (yr) 36±6.1
BMI (kg/m2) 22.5±2.8
Manual semen analysis according to WHO manual for semen analysis
 Volume (mL) 2.3±0.7
 Sperm concentration (×106/mL) 41.8 (8–114)
 Motility (%) 44.8 (24–71)
 Motile sperm concentration (×106/mL) 13.9 (2–61)
 Progressive (%) 31.8 (12–56)
 Non-progressive (%) 13.3 (6–24)
 Immotile (%) 55 (22.5–76)
 Vitality (%) 41 (20–59)

Values are presented as mean±standard deviation or median (range).

BMI, body mass index; WHO, World Health Organization.

Table 2.
Parameter values for CASA and home mobile sperm testing with the YO Home Sperm Test
Variable Value
CASA
 Sperm concentration (×106/mL) 18.6 (4–75)
 Motility (%) 72.6 (23.1–91.6)
 Motile sperm concentration (×106/mL) 13.2 (0.4–63.8)
 Progressive motility (%) 60.2 (19.6–79.9)
 Non-progressive motility (%) 12 (6.5–17.9)
 Immotile (%) 27.5 (8.4–70.3)
Home mobile sperm testing
 Home mobile sperm testing score 20 (0–60)

Values are presented as median (range).

CASA, computer-assisted semen analysis.

References

1. Ducot B, Spira A, Feneux D, Jouannet P. Male factors and the likelihood of pregnancy in infertile couples: II. Study of clinical characteristics: practical consequences. Int J Androl 1988;11:395-404.
crossref pmid
2. Zinaman MJ, Brown CC, Selevan SG, Clegg ED. Semen quality and human fertility: a prospective study with healthy couples. J Androl 2000;21:145-53.
crossref pmid
3. World Health Organization. WHO laboratory manual for the examination and processing of human semen. 5th ed. World Health Organization; 2010.

4. Auger J, Eustache F, Ducot B, Blandin T, Daudin M, Diaz I, et al. Intra- and inter-individual variability in human sperm concentration, motility and vitality assessment during a workshop involving ten laboratories. Hum Reprod 2000;15:2360-8.
crossref
5. Kobori Y. Home testing for male factor infertility: a review of current options. Fertil Steril 2019;111:864-70.
crossref pmid
6. Gonzalez D, Narasimman M, Best JC, Ory J, Ramasamy R. Clinical update on home testing for male fertility. World J Mens Health 2021;39:615-25.
crossref pmid pdf
7. Coppola MA, Klotz KL, Kim KA, Cho HY, Kang J, Shetty J, et al. SpermCheck fertility, an immunodiagnostic home test that detects normozoospermia and severe oligozoospermia. Hum Reprod 2010;25:853-61.
crossref pmid pmc
8. Elzanaty S, Malm J. Comparison of semen parameters in samples collected by masturbation at a clinic and at home. Fertil Steril 2008;89:1718-22.
crossref pmid
9. Agarwal A, Panner Selvam MK, Sharma R, Master K, Sharma A, Gupta S, et al. Home sperm testing device versus laboratory sperm quality analyzer: comparison of motile sperm concentration. Fertil Steril 2018;110:1277-84.
crossref pmid
10. Makler A. The improved ten-micrometer chamber for rapid sperm count and motility evaluation. Fertil Steril 1980;33:337-8.
crossref pmid
11. Hamilton Thorne. CASA II Human Research SW V1.13 [Internet]. Haminton Thorne Inc.; 2020 [cited 2026 Aug 4]. Available from: https://www.hamiltonthorne.com

12. Amann RP, Waberski D. Computer-assisted sperm analysis (CASA): capabilities and potential developments. Theriogenology 2014;81:5-17.
crossref pmid
13. Akashi T, Mizuno I, Okumura A, Fuse H. Usefulness of sperm quality analyzer-V (SQA-V) for the assessment of sperm quality in infertile men. Arch Androl 2005;51:437-42.
crossref pmid
14. Kanakasabapathy MK, Sadasivam M, Singh A, Preston C, Thirumalaraju P, Venkataraman M, et al. An automated smartphone-based diagnostic assay for point-of-care semen analysis. Sci Transl Med 2017;9:eaai7863.
crossref pmid pmc
15. Nallella KP, Sharma RK, Aziz N, Agarwal A. Significance of sperm characteristics in the evaluation of male infertility. Fertil Steril 2006;85:629-34.
crossref pmid
16. Schaff UY, Fredriksen LL, Epperson JG, Quebral TR, Naab S, Sarno MJ, et al. Novel centrifugal technology for measuring sperm concentration in the home. Fertil Steril 2017;107:358-64.e4.
crossref pmid
17. Yu S, Rubin M, Geevarughese S, Pino JS, Rodriguez HF, Asghar W. Emerging technologies for home-based semen analysis. Andrology 2018;6:10-9.
crossref pmid pdf
18. Honig S, Rabinovitch L, Bar-Chama N. YO® home sperm test’s motile sperm concentration and YO SCORE™ correlates with automated semen analysis™ results. Fertil Steril 2019;112:e361.
crossref
19. Jorgensen N, Andersen AG, Eustache F, Irvine DS, Suominen J, Petersen JH, et al. Regional differences in semen quality in Europe. Hum Reprod 2001;16:1012-9.
crossref pmid
20. Redmon JB, Thomas W, Ma W, Drobnis EZ, Sparks A, Wang C, et al. Semen parameters in fertile US men: the Study for Future Families. Andrology 2013;1:806-14.
crossref pmid pmc
21. Bhongade MB, Prasad S, Jiloha RC, Ray PC, Mohapatra S, Koner BC. Effect of psychological stress on fertility hormones and seminal quality in male partners of infertile couples. Andrologia 2015;47:336-42.
crossref pmid
22. Branigan EF, Estes MA, Muller CH. Advanced semen analysis: a simple screening test to predict intrauterine insemination success. Fertil Steril 1999;71:547-51.
crossref pmid
23. Shulman A, Hauser R, Lipitz S, Frenkel Y, Dor J, Bider D, et al. Sperm motility is a major determinant of pregnancy outcome following intrauterine insemination. J Assist Reprod Genet 1998;15:381-5.
crossref pmid pmc pdf
24. Lin SS, Chen CY, Lin CM, Chiang TC, Tang YS, Yeh CC, et al. A mobile sperm analyzer with user-friendly microfluidic chips for rapid on-farm semen evaluation. Biosensors (Basel) 2025;15:394.
crossref pmid pmc
TOOLS
Share :
Facebook Twitter Linked In Google+ Line it
METRICS Graph View
  • 0 Crossref
  •   Scopus
  • 285 View
  • 15 Download
Related articles in Clin Exp Reprod Med


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
AUTHOR INFORMATION
Editorial Office
Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital
82 Gumi-ro 173, Bundang-gu, Seongnam 13620, Korea
Tel: +82-31-787-7254    CP: +82-10-9072-3154    E-mail: blasto@snubh.org                

Copyright © 2026 by Korean Society for Reproductive Medicine.

Developed in M2PI

Close layer
prev next